Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-02-04

FDA Approved: DAPSONE — Original Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved an original application for DAPSONE from Mylan Pharmaceuticals, granting generic market authorization.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DAPSONE (dapsone)

Snippet

ORIG AP for DAPSONE (DAPSONE)